Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Cryo-Cell International, Inc.

Cryo-Cell International, Inc. (CCEL) Stock Overview

Explore Cryo-Cell International, Inc.’s financial performance, market position, analyst ratings, and future outlook.

CCEL●AMEX
HealthcareMedical - Care Facilities
$4.87
$0.04(0.92%)
U.S. Market opens in 1h 15m

Cryo-Cell International, Inc. (CCEL)

Meyka AI Score

Z

Key Financials

Market Cap39.7M
P/E Ratio-22.26
EPS (TTM)$-0.23
ROE0.16%
Fundamental Analysis

AI Price Forecasts

1 Month$5.05
3 Months$4.89
1 Year Target$3.00

CCEL Stock Analysis & Investment Overview (AMEX)

Our AI-powered analysis of Cryo-Cell International, Inc. (AMEX: CCEL) gives investors deep insight into how the stock performs on the AMEX exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Cryo-Cell International, Inc.'s AMEX-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CCEL on the AMEX shows an RSI of 55.26, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $3.00 for the AMEX listing.

Key metrics behind Cryo-Cell International, Inc.'s AMEX-traded stock include a P/E ratio of -22.26 and a market capitalization of 39.7M. Combined with our AI analysis, these give both institutional and retail investors a clear view of CCEL on the AMEX.

Price Performance (AMEX: CCEL)

1-Day Change
0.10%
5-Day Change
-2.77%
1-Month Change
12.84%
3-Month Change
40.17%
6-Month Change
42.61%
Year-to-Date (YTD) Change
43.02%
1-Year Change
15.76%
3-Year Change
-4.47%
5-Year Change
-58.31%
All-Time (Max) Change
-1.60%

Contact Information

https://www.cryo-cell.com
813 749 2100
700 Brooker Creek Boulevard, Oldsmar, FL, 34677

Company Facts

740 Employees
IPO DateApr 4, 1994
CountryUS
Actively Trading

Frequently Asked Questions